The changing microbiological and antimicrobial susceptibility profile of cerebrospinal fluid organism isolates in a teaching hospital, Tangerang, Indonesia

Authors

  • Cucunawangsih Cucunawangsih Pelita Harapan University
  • Veronica Wiwing
  • Nata PH Lugito
  • Vivien Puspitasari

DOI:

https://doi.org/10.3823/772

Keywords:

antimicrobial, susceptibility, neurosurgical procedures, CNS infections

Abstract

Central nervous system (CNS) infections have become serious problems that contribute to morbidity and mortality in developing countries. In the recent years, antimicrobial resistance has arisen parallel with the changing trend of infectious pathogens, which resulted in the unavailability of an ideal antimicrobial agent. This study was designed to evaluate the central nervous system pathogens and their susceptibility profile using routine microbiological data. The data of CSF culture and susceptibility testing were collected from January 2010 to August 2015. The majority of eligible sample 68/99 (68.7%) had history of neurosurgical procedures. The most common pathogens isolated were coagulase negative staphylococci (CoNS) 39/99 (39.4%) followed by Acinetobacter baumanii 10/99 (10.1%), Pseudomonas aeruginosa 7/99 (7.1%), Sphingomonas paucimobilis 5/99 (5.0%), and Aeromonas salmonocida 4/99 (4.0%). Almost of all Gram positive cocci were susceptible to tigecycline, linezolide, vancomycin, and trimethoprim/sulfamethoxazole. Most Gram negative bacilli (GNB) in this study were multi-drug resistant with high susceptibility level to amikacin, tigecycline, and trimethoprim/sulfamethoxazole. The overall susceptibility testing to cephalosporins was low, ranging 34.2% to 58.5%. The susceptibility to several antifungal remained high for Candida spp. and Cryptococcus neoformans. The present study notifies the changing pathogens trend of CNS infections along with their antimicrobial susceptibility level in our hospital. There is a need of local antimicrobial recommendation and surveillance system to control the usage of antimicrobial and selection of empirical antimicrobial therapy.

Author Biography

Cucunawangsih Cucunawangsih, Pelita Harapan University

Microbiology Department

References

Ho Dang Trung N, Le Thi Phuong T, Wolbers M, Nguyen Van Minh H, Nguyen Thanh V, Van MP, et al. Aetiologies of Central Nervous System Infection in Viet Nam: A Prospective Provincial Hospital-Based Descriptive Surveillance Study.PLoS ONE 2012; 7(5): e37825. doi:10.1371/journal.pone.0037825.

Marchiori PE, Lino AMM, Machado LR, PedaliniLM, BoulosM, Scaff M. NeuroinfectionSurvey at a Neurological Ward in a Brazilian Tertiary Teaching Hospital.Clinics 2011;66(6): 1021-1025.

Vengamma B, Rajguru M, Prasad BCM, Ramesh-Chandra VV.Central Nervous System Infections in the Intensive Care Unit. J ClinSci Res 2014; 3: 106-113.

McClelland III S, Hall WA. Postoperative Central Nervous System Infection: Incidence and Associated Factors in 2111 Neurosurgical Procedures. CID 2007; 45: 55-59.

Yadegarynia D, Gachkar I, Fatemi A, Zali A, Nobari N, Asoodck M, Parsaieyan Z. Changing Pattern of Infectious Agents in PostneurosurgicalMeningitis. Caspian J Intern Med.2014; 5 (3): 171-175.

Buang SS, Haspani MS. Risk Factors for Neurosurgical Site Infections after a Neurosurgical Procedure: A Prospective Observational Study at Hospitals Kuala Lumpur. Med J Malaysia. 2012: 67(4): 393-398.

Srinivas D, VeenaKumari HB, Somanna S, Bhagavatula I, Anandappa CB. The Incidence of Postoperative Meningitis in Neurosurgery: An Institutional Experience.Neurol India 2011; 59: 195-198.

Ravikumar R, Iyothi EK, Dutta BS, Vidyasagar K, Nandan TM, Ashalatha G. Infections by Multidrug Resistant Organisms in a Neurosurgical and Neuropsychiatric Care Centre and the Changing Antimicrobial Susceptibility Patterns. Journal of Evolution of Medical and Dental Sciences 2012; 1 (4): 444-452.

Maloka MH, Miller WC, Hoffman IF, Cholera R, Gilligan PH, Kamwendo D, et al. Bacterial Infections in Lilongwe, Malawi: Aetiology and Antibiotic Resistance. BMC Infectious Diseases 2012; 12: 67. http://www.biomedcentral.com/1471-2334/12/67.

Gitali B, Dipa B, Naba HK, Jasmin H, Sharon RR. Bacteriological Profile of Acute Meningitis: A One Year Study in a Tertiary Care Centre in Assam. Indian Journal of Public Health and Development 2014; 5 (3): 210-214.

Mani R, Nagarathna S, Wasiulla R, Chandramuki A. Bacteriological Profile of Community Acquired Bacterial Meningitis: A Ten-Year Restrospective Study in a Tertiary Neurocare Centre in South India. Indian Journal of Medical Microbiology 2007; 25 (2): 108-114.

van de Beck D, de Gans J, Tunkel AR, Wijdicks E F. Community Acquired Bacterial Meningitis in Adults. N Engl J Med 2006; 354: 44-53.

Clinical and Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement 2002; 32 (3): 64-65.

Sudiro TM, Soebandrio A, Prawoto, Sudarmono P. Resistance Pattern of Mycobacterium tuberculosis to First-Line Antituberculosis Drugs. Med J Indones2000; 9 (3): 153-156.

Mengistu A, Gaeseb J, Uaaka G, Ndjavera C, Kambyambya K, Indongo L. Antimicrobial Sensitivity Patterns of Cerebrospinal Fluid (CSF) Isolates in Namibia: Implications for Empirical Antibiotic Treatment of Meningitis. Journal of Pharmaceutical Policy and Practice 2013; 6: 4. doi:10.1186/2052-3211-6-4.

Rezaeizadeh G, Pourakbari B, Ashtiani MH, Asgari F, Mahmoudi S, Mamishi S. Antimicrobial Susceptibility of Bacteria Isolated from Cerebrospinal Fluids in an Iranian Referral Pediatric Centre, 1998-2008.Maedica A Journal of Clinical Medicine 2012; 7 (2): 131-137.

Moon C, Kwak YG, Kim BN, Kim ES, Lee CS. Implications of Postneurosurgical Meningitis Caused by Carbapenem-Resistant Acinetobacter baumanii. J Infect Chemother2013; 19: 916-919.

Morfin-Otero R, Alcantar-Curiel MD, Rocha MJ, Alpuche-Aranda CM, Santos-Preciado JI, Gayosso-Vazquez C, et al. Acinetobacter baumanii Infections in a Tertiary Care Hospital in Mexico Over the Past 13 Years. Chemotherapy 2013; 59: 57-65.

AbboA, Carmeli Y, Navon-Venezia S, Siegman-Igra Y, Schwaber MJ. Impact of Multi-drug Resistant Acinetobacter baumanii on Clinical Outcomes. EurJClinMicrobiol Infect Dis 2007; 26: 793-800.

Downloads

Published

2015-12-13

Issue

Section

Articles